If you're looking for another Insilico Medicine, BenchSci is worth a look. Its ASCEND platform uses AI to speed up drug discovery and other complex research workflows, taking advantage of a big data set and biology-focused multimodal AI to understand experiments. It's got tools like generative AI-boosted summarization and conversational AI that can help you decide what experiments to run and cut down on failures.
Another contender is QIAGEN Digital Insights. This bioinformatics software suite offers expert-curated solutions for genomic and clinical research, helping you turn basic research into patient care. It includes tools for annotating and filtering variants, genomic data analysis and clinical services, and is a good choice for biomarker and target discovery, single-cell genomics and more.
Genesis Therapeutics has a molecular AI platform designed to speed up small molecule drug discovery with 3D spatial graph modeling and molecular simulation. The GEMS platform predicts properties and generates molecules, with the goal of developing high-potency and selective small molecule drugs for hard-to-drug biological targets. It's a good fit for tackling breakthrough treatments for challenging diseases.
Last, Tempus has an AI-powered precision medicine platform designed to improve cancer care by providing patient insights, care gap identification and real-world data analysis. It can help pharmaceutical and biotech companies develop drugs and clinical trials and offer personalized therapy options to patients. It's backed by scientific publications and has received FDA Breakthrough Device Designation for its HLA-LOH Companion Diagnostic Test.